Event in Progress:
Discover the latest content that has just been published on Research Tree
A great 9M23 overall with a standout performance attributed to GEMS during the H1. Although the Q3 results were weaker compared to 2022, Engie raised its FY23 guidance while maintaining a wide €1bn range on the EBIT reflecting a cautious view of Q4. It is likely to be affected by a 2022 base effect while the management estimates that demand for gas among European industrial customers has seen 10% to 20% volume destruction since 2022 and that this is unlikely to be recovered.
Companies: Engie (ENGI:EPA)ENGIE SA. (ENGI:PAR)
AlphaValue
Engie released an adjusted EBITDA excluding Nuclear for H1 23 of €8.8bn, up by €2bn yoy, beating market expectations. As in Q1, 95% of the outperformance was achieved by Other, for which the group has already indicated that a normative EBIT should be around €1bn on an annual basis. So beware of the hype surrounding these excellent figures!
Engie and the Belgian government have signed an agreement on the 10-year extension of the two nuclear plants Doel 4 and Tihange 3 with a re-start as of November 2026. Engie and the CPN have also found a common ground on provisions for waste liabilities. After tough discussions, the two parties agreed on a fixed €15bn amount, resulting in an additional €4.5bn provision charge in FY23 and corresponding to c.55% of the EBIT FY23.
An excellent first quarter for Engie with another strong contribution from Global Energy Management & Sales (GEMS), accounting for 38% of the total EBIT at €1.6bn. To a lesser extent, renewables benefited from higher prices and volumes which contributed with GEMS to offsetting the slowdown in retail and nuclear. The group has shifted the 2023 guidance to the top-end with an EBIT excluding nuclear of €6.6-7.6bn and a net income group share of €3.4-4.0bn but remains conservative due to the expecte
As mentioned in our previous publication, Engie’s dark cloud remains the future of the its nuclear fleet in Belgium in the face of political contradictions but also the CPN’s increased requirements. In fact, the Belgian government required a 10 year-extension of the two last nuclear plants but is still in negotiations with the French energy player which is delaying the final agreement, while the CPN provision requirements is overhanging Engie’s horizon and preventing a clear outlook.
Unsurprisingly Engie delivered a strong operational and financial performance in 2022, benefitting from unprecedented commodity market prices and volatility, pushing the earnings from GEMS, thermal and renewables to exceptional levels. These record results set the group on the right track for 2023 and put it in a strong position to invest in renewables but also propose an exceptional dividend. Despite a complicated and costly Belgian nuclear dismantling, the group managed to retain a relevant fi
The major French utility delivered a very impressive performance for this third quarter 2022, with a 49% rise in EBITDA to €10.7bn, driven by strong trading activities through the GEMS division but also by growth in the thermal and supply business units, and in renewables. Engie confirmed its winning position in a highly-volatile energy market environment and its commitment to playing a leading role to support the security of supply in Europe. The guidance for FY2022 was upgraded.
Engie released a very strong set of results, with EBITDA surging by more than 43% and net income multiplying by 2.5x. No doubt on the drivers: the trading desk and nuclear generation have become cash cows. The rather conservative guidance was however confirmed. The group also reduced its exposure to Gazprom and Russian gas, while it engaged in manoeuvres to keep the threat of windfall taxes at bay as far as possible.
Engie released a set of very strong Q1 22 results, above expectations, driven by its thermal, nuclear and trading activities. As a result, the guidance is improved by more than 20% on the back of more realistic assumptions thus correcting the black spot in the FY21 results. The lower exposure to Russian gas is also worthy of note to reassure investors and to bring some confidence back into an over-sanctioned stock for several months. More than ever, Buy.
Engie beat our expectations on the FY21 results driven by the remarkable performance of its nuclear assets. While some might think of this as a one-off, the group has confirmed with a set of solid targets for 2022-24, paving the way for continuous growth after turning the page on nuke and Equans, even if conservative assumptions leave room for upside. Note, however, a slight disappointment in the dividend, with €0.85 proposed vs €0.90 expected, and net debt affected by margin calls.
Engie released a very strong set of 9M 21 results and, for the second time in a row, upgraded its FY21 guidance substantially. After the sale of Equans at a very interesting price, the group also announced the purchase of Eolia, a Spanish renewables pure play with 0.9GW of operating assets, with Crédit Agricole (40%/60%). More than ever, Engie confirms the attractiveness of its investment case by operating its strategic revamping in a very efficient way. Positive recommendation reaffirmed.
What if the best solution for the energy transition were … nuclear power? Nuke is back at the heart of political debates in the context of the current energy crisis and massive but insufficient investments in renewables. This short review provides an overview of nuclear power in Europe and speculates on options. This ‘nuke optionality’, hinging on a favourable green taxonomy, is a game-changer for EDF, Centrica, Fortum but also Engie, Iberdrola, Enel and EDP.
Driven by nuclear power, weather-related demand and the increase in power prices, Engie released a set of strong H1 figures. EBIT is up by 44.4% in organic terms, while group recurring net profit jumped by 67%. This led to guidance being improved by €200-300m at EBITDA, EBIT and net result levels. The sale of an 11.5% equity stake in GRTgaz will decrease net indebtedness, while the bidding process of Equans is also on track, with further information in H2. Positive recommendation confirmed.
Expected for months now, Engie finally unveiled its roadmap for the coming years to show its operating organisation and expansion in renewables. This involves €9-10bn of disposals (including Bright) and €15-16bn of investments by 2023 to move towards the successful scheme of a strong expansion in green assets backed by the network cash-cow. A promising move, midway between the merciless capacity-driven utility race and the cautiousness that such a strategy requires. Positive view confirmed.
A solid start to the year from Engie. Except for Renewables, which were strongly affected by adverse events in the Americas, all activities exhibited growth and drove EBIT up by 10% organically. In particular, the cold weather in Europe increased both energy volumes and prices. FY21 guidance reaffirmed, as much as our positive view.
Research Tree provides access to ongoing research coverage, media content and regulatory news on ENGIE SA.. We currently have 76 research reports from 3 professional analysts.
Companies: FOG PHC FEN BBSN ELIX
Cavendish
Headlam Group has laid out an ambitious long-term revenue target of between £900m and £1bn, as it seeks to grow its share of the UK floor coverings distributor market. Despite a challenging backdrop due to the low level of residential housing transactions, management is seeking to expand each of its sales channels: Trade Counters, Larger Customers, Regional Distribution and Europe & Other. The FY23 results reflected the more challenging environment and the group trades at a discount to its long-
Companies: Headlam Group plc
Edison
Companies: CLA STM GLN FXPO KAV GWMO CEY BHP THX EEE
SP Angel
Companies: James Latham Plc
The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no
Companies: AEIT ROOF DGI9 INPP GSF SEIT USFP HICL ORIT BSIF TRIG NESF SEQI HEIT GRP GCP FSFL 3IN AERI PINT RNEW BBGI GSEO DORE TENT GRID CORD HGEN AEET
Hardman & Co
Companies: Gattaca plc
Liberum
Companies: Severfield Plc
Quadrise (QED LN) has provided an update on its Utah project with Valkor. Valkor’s partner (Heavy Sweet Oil LLC) has received funding and approval to commence drilling enabling production of 20-40bopd of heavy sweet oil providing QED with samples for production of test scale quantities of MSAR and bioMSAR; the company’s key fuel decarbonising emulsion fuel products. This should derisk the commercial scale ramp up. QED management has highlighted that Valkor has not yet raised the minimum of US$
Companies: Quadrise PLC
VSA Capital
AUCTUS PUBLICATIONS ________________________________________ Tethys Oil (TETY SS)C; target price of SEK100 per share: Increasing further the size of the prize/Considering Algeria – The South Lahan area on Block 58 is estimated to hold 55-523 mmbl prospective resources (P90-P10 case) with a mean case of 251.8 mmbbl prospective resources across six prospects in the Ara Carbonate. Combined with the previously disclosed prospective resources of the Fahd area in the north-eastern part of Block 58, Te
Companies: OKEA WDS GALP RHC RHC ENW EOG UJO TRIN I3E SCIR ZPHR SDX CRCL UOG TETY CEG IOX 0EVE CNE VAR TETY VLE GALP OKEA
Auctus Advisors
22nd April 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced Dish of the day Admissions: Delistings: What’s baking in the oven? ** Potential**** Initial Public Offerings: Reverse Takeovers: 16 April 2024: Electric Guitar (ELEG.L) Concurrent with its Admission to trading on AIM, Electric Guitar is proposing to acquire the entire issued share capital of 3radi
Companies: ARV CTL AFRN FEN HUW TENG BBSN EAAS VAL
Hybridan
Companies: SigmaRoc Plc
Another Good Year of Diversified Growth with More to Come in 2024 CCapital have released their Q1 operating results. Overall, revenue has come in slightly lower than expected at $80.2m vs TamE of $85.9m but is largely tracking in line with our FY24 annual estimate and we note the company has maintained guidance. Drilling revenue for this quarter was impacted by a fall in utilisaztion rates as well as general remobilisation geographically but we expect a strong recovery throughout the year as k
Companies: Capital Limited
Tamesis Partners
Epwin’s FY23 results show a strong performance in both absolute and relative terms with operating profit increasing 19% yoy to £25.5m (FY22: £21.5m) as the margin expanded 140bps yoy to 7.4%.
Companies: Epwin Group PLC
Zeus Capital
Companies: FOG PEB KBT EMR TIME GETB JNEO
Banquet Buffet*** Abingdon Health 9.25p £11.3m (ABDX.L) The lateral flow contract development and manufacturing organisation announces its unaudited interim results for the six months ended 31 December 2023. Revenue increased 117% to £2.4m (H1 2023: £1.1m). The Adjusted EBITDA loss decreased 47% to £1.2m (H1 2023: £2.2m). Furthermore, reduction in operating loss of 50% to £1.2m (H1 2023: £2.4m). The Board therefore expects that H2 2024 revenue will be significantly improved compared with H1 2024
Companies: CPX SLP FA/ FIPP ECR ETP ORCA
Share: